Treatment of bone marrow aplasia by mismatched bone marrow transplantation after conditioning with antilymphocyte globulin--long-term results
- PMID: 136773
Treatment of bone marrow aplasia by mismatched bone marrow transplantation after conditioning with antilymphocyte globulin--long-term results
Abstract
Twenty patients with very severe bone marrow aplasia were treated with mismatched bone marrow transplants. Engraftment and transitory chimerism (from 2-10 months) not complicated by secondary disease occurred in 4 patients. Of these, 3 are still alive after 5 years, with a compensated hematologic status. Engraftment failed in 16 patients; only 1 of these is still alive after 5 years.
Similar articles
-
Treatment of bone marrow aplasia by bone marrow graft after conditioning with antilymphocyte globulin. Long term results.Exp Hematol. 1976 Jul;4(4):256-64. Exp Hematol. 1976. PMID: 782897 No abstract available.
-
Treatment of acquired severe aplastic anemia.Am J Pediatr Hematol Oncol. 1989 Fall;11(3):360-7. Am J Pediatr Hematol Oncol. 1989. PMID: 2675662 Review.
-
Rationale for the use of ALG as sole immunosuppressant in allogeneic bone marrow transplantation for aplastic anemia.Transplant Proc. 1976 Dec;8(4):617-22. Transplant Proc. 1976. PMID: 11593 Review. No abstract available.
-
[Bone marrow transplantation for severe aplastic anemia].Medicina (B Aires). 1998;58(2):130-4. Medicina (B Aires). 1998. PMID: 9706244 Clinical Trial. Spanish.
-
Bone marrow transplantation in 65 patients with severe aplastic anemia.Bull Cancer. 1981;68(1):74-7. Bull Cancer. 1981. PMID: 7013871
Cited by
-
Immunosuppression for myelodysplastic syndrome: how bench to bedside to bench research led to success.Hematol Oncol Clin North Am. 2010 Apr;24(2):331-41. doi: 10.1016/j.hoc.2010.02.009. Hematol Oncol Clin North Am. 2010. PMID: 20359629 Free PMC article. Review.
-
Aplastic anemia: immunosuppressive therapy in 2010.Pediatr Rep. 2011 Jun 22;3 Suppl 2(Suppl 2):e7. doi: 10.4081/pr.2011.s2.e7. Pediatr Rep. 2011. PMID: 22053283 Free PMC article.